Lion Air, Southeast Asia’s second largest low-cost airlines (LCCs), finally joined the increasing list of companies choosing to delay or cancel capital raising activities this year on account of the novel coronavirus. To name two more, Chinese biotech InnoCare, which develops treatments for autoimmune diseases, has delayed investor meetings in Hong Kong, and Japanese restaurant operator Daikiya Group Holdings postponed their plans to go public.